StockDrifts LogoStockDrifts

Dongkuk Pharmaceutical 086450

Company
동국제약Dongkuk Pharmaceutical
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2025-10-14

Dongkuk Pharmaceutical (086450) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Dongkuk Pharmaceutical is dated 2024-04-04; the most recent is 2025-10-14. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-10-14SELL전환등
디케이앤컴
DK&COM
--346.7K₩18,320-12.2%₩6.4B ($4.4M)
2025-10-14BUY기타
디케이앤컴
DK&COM
-346.7K₩18,320+12.2%₩6.4B ($4.4M)
2024-04-04BUY자사주상여금
오흥주
Heungju Oh
vice president6.0K₩16,620+23.6%₩100M ($69K)

Frequently asked questions

Who has been buying Dongkuk Pharmaceutical stock?
0 distinct insiders have filed 0 disclosed insider purchases in Dongkuk Pharmaceutical (086450), most recently on 2025-10-14. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Dongkuk Pharmaceutical have?
Dongkuk Pharmaceutical has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-04-04 to 2025-10-14.
Where does StockDrifts get Dongkuk Pharmaceutical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Dongkuk Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.